IOVANCE BIOTHERAPEUTICS, INC. (IOVA) /
The profitability of IOVANCE BIOTHERAPEUTICS, INC. over the past 10 years
Chart IOVANCE BIOTHERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →IOVANCE BIOTHERAPEUTICS, INC. reported a net loss of $390.98M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $90.32M and an operating loss of $403.36M. It reported a loss in all 10 years shown.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $90.32M* | -$403.36M | -$390.98M |
| 2024ended Dec 31, 2024 | $70.82M* | -$395.28M | -$372.18M |
| 2023ended Dec 31, 2023 | $156K* | -$460.56M | -$444.04M |
| 2022ended Dec 31, 2022 | — | -$398.88M | -$395.89M |
| 2021ended Dec 31, 2021 | — | -$342.7M | -$342.25M |
| 2020ended Dec 31, 2020 | — | -$261.94M | -$259.58M |
| 2019ended Dec 31, 2019 | — | -$206.87M | -$197.56M |
| 2018ended Dec 31, 2018 | — | -$128.26M | -$123.58M |
| 2017ended Dec 31, 2017 | — | -$92.88M | -$92.06M |
| 2016ended Dec 31, 2016 | — | -$53.64M | -$52.89M |
Fiscal years as IOVANCE BIOTHERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IOVANCE BIOTHERAPEUTICS, INC.
- The revenue of IOVANCE BIOTHERAPEUTICS, INC.
- The cash flow of IOVANCE BIOTHERAPEUTICS, INC.
- The debt of IOVANCE BIOTHERAPEUTICS, INC.
- All of IOVANCE BIOTHERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- SMGScotts Miracle-Gro Co
- COCOThe Vita Coco Company, Inc.
- CNRCore Natural Resources, Inc.
- AZZAZZ Inc.
- KGSKodiak Gas Services, Inc.
Not investment advice. This page shows what IOVANCE BIOTHERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.